Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity

Phase 2 Completed 80 enrolled University Hospital, Ghent

RandomizedSingle-groupOpen-labelTreatment

Summary

Evaluation of the effect of intrathecal administration of Baclofen on spasticity of cerebral palsy patients, by means of standardized and internationally accepted scales

Timeline

Start: 2000-01
Primary completion: —
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Baclofen	Small molecule	—	Intrathecal

Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity

Summary

Timeline

Drugs

Indications